| Financial Year |
March 31 2023 |
| Monetary Funds |
5,831,350,174.92 |
| Held-for-trading Financial Assets |
1,550,573,926.23 |
| Notes Receivable |
244,232,471.34 |
| Accounts Receivable |
4,614,316,668.03 |
| Advances to Suppliers |
334,484,562.16 |
| Other Receivables |
487,710,431.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,625,446,213.87 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,621,644,707.65 |
| Other Current Assets |
138,091,659.84 |
| Total Current Assets |
20,297,448,767.58 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
700,022,752.82 |
| Long-term Equity Investment |
156,822,658.77 |
| Investment Properties |
50,275,914.11 |
| Fixed Assetes |
3,438,550,866.32 |
| Under-construction Projects |
55,693,702.24 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
621,184,790.06 |
| R&D expenses |
-- |
| Goodwill |
89,647,978.61 |
| Long-Term Deferred and Prepaid Expenses |
27,050,813.74 |
| Deferred Income Tax Assets |
420,638,727.05 |
| Other Non-Current Assets |
648,643,115.64 |
| Sub-Total of Non-Current Assets |
7,727,812,526.67 |
| Total Assets |
28,025,261,294.25 |
| Short-Term Loans |
1,201,316,532.14 |
| Trading Financial liabilities |
17,841,340.39 |
| Notes Payable |
7,211,408,671.23 |
| Accounts Payable |
6,317,059,113.06 |
| Accounts Received In Advance |
413,387,420.06 |
| Employee Compensation Payable |
280,636,909.82 |
| Taxes Payable |
35,658,901.20 |
| Interest Payable |
-- |
| Dividend Payable |
12,052,795.08 |
| Other payables |
621,154,713.19 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
828,357,520.73 |
| Other Current Liabilities |
57,764,197.55 |
| Sub-Total of Current Liabilities |
18,244,888,328.00 |
| Long-term Loans |
3,558,951,044.02 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,333,157.76 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,111,423,968.62 |
| Deferred Income Tax Liabilities |
17,217,018.79 |
| Other Non-Current Liabilities |
206,520,710.51 |
| Sub-Total of Non-Current Liabilities |
5,289,965,236.05 |
| Total Liabilities |
23,534,853,564.05 |
| Paid-In Capital(Or Share Stock) |
717,047,417.00 |
| Capital Surplus |
1,385,145,467.72 |
| Surplus Reserve |
273,971,687.41 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
667,435,899.57 |
| Minority Stockholder's Interest |
918,444,471.96 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,571,963,258.23 |
| Owner's Equity（Stockholder's Equity） |
4,490,407,730.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
28,025,261,294.24 |
